Hospital mergers do not result in financial benefits

By Admin
Hospital mergers are often seen as one of the only solutions for cash-strapped hospitals to boost their financial credibility. However, a new study has...

Hospital mergers are often seen as one of the only solutions for cash-strapped hospitals to boost their financial credibility.

However, a new study has suggested that hospital mergers might not be as beneficial to the organisations as previously thought.

Apparently, after two hospitals merge together there are no benefits to the levels of patient care, waiting times or financial performance for either hospital.  

It has even been revealed that instead of improving a hospital’s financial standings, they can in fact worsen following a merger.

 To read the latest edition of Healthcare Global, click here

Additionally, patient waiting times increased in recently merged hospitals.

The study in the success of hospital mergers was carried out by the Centre for Marketing and Public Organisation (CMPO) at the University of Bristol in the UK.

It was also funded by the Department of Health’s policy research programme and investigated the success of 110 hospital mergers that occurred between 1997 and 2006.

During this period, roughly half of acute hospitals in the UK merged and the results have been released just as the British government is advising hospitals to merge to boost their financial prospects.

Professor Carol Propper, who led the study, discovered that newly-partnered hospitals recorded increased losses after the merger than they did before.

“Our findings suggest that policies to reduce the scope for competition may not be beneficial for patients or taxpayers,” Propper commented.

“Mergers reduce the scope for competition between hospitals.

“And we know from other recent research that – just as in the private sector – regulated competition may be beneficial in the NHS.”

The Healthcare Global magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare